首页> 外国专利> Peptide immunogen targeting calcitonin gene-related peptide (CGRP) and formulations thereof for prevention and treatment of migraine

Peptide immunogen targeting calcitonin gene-related peptide (CGRP) and formulations thereof for prevention and treatment of migraine

机译:用于预防和治疗偏头痛的以降钙素基因相关肽(CGRP)为靶向的肽免疫原及其制剂

摘要

The present disclosure relates to peptide immunogen constructs targeting portions of calcitonin gene-related peptide (CGRP), compositions containing the constructs, antibodies and constructs induced by the constructs, and methods of making and using compositions thereof will be. The disclosed peptide immunogen constructs have greater than about 30 amino acids and contain (a) greater than about 7 contiguous amino acid residues from the CGRP receptor binding or activation region of the full-length CGRP protein to a B cell epitope; (b) a heterologous Th epitope; and (c) an optional heterologous spacer. The disclosed CGRP peptide immunogen constructs stimulate the production of highly specific antibodies to CGRP for the prevention and/or treatment of migraine.
机译:本发明涉及靶向降钙素基因相关肽(CGRP)部分的肽免疫原构建体、含有该构建体的组合物、抗体和由该构建体诱导的构建体,以及制备和使用其组合物的方法。所公开的肽免疫原构建体具有大于约30个氨基酸,并且包含(a)从全长CGRP蛋白的CGRP受体结合区或激活区到B细胞表位的大于约7个相邻氨基酸残基;(b) 异源Th表位;和(c)可选的异种间隔物。所公开的CGRP肽免疫原构建物刺激产生针对CGRP的高度特异性抗体,用于预防和/或治疗偏头痛。

著录项

  • 公开/公告号KR20220041039A

    专利类型

  • 公开/公告日2022-03-31

    原文格式PDF

  • 申请/专利权人 유나이티드 뉴로사이언스 리미티드;

    申请/专利号KR1020217023967

  • 发明设计人 왕 창 이;

    申请日2019-12-31

  • 分类号A61K31/433;A61K31/166;A61K31/415;A61K45/06;A61P25;A61P25/16;A61P25/28;

  • 国家 KR

  • 入库时间 2024-06-14 22:54:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号